- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (718)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (6)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (170)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (628)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (64)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (898)
- Research (392)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (604)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (322)
- Symptoms (184)
- Treatment (1776)
Quit-smoking toolkit targets residents of public housing
2 minute read | Published May 10, 2018
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on May 10, 2018
By July 31, all U.S. Department of Housing and Urban Development (HUD) housing will be required to be smokefree, in accordance to rule put into effect in 2017. An estimated 420,000 Americans who smoke and live in HUD housing, many of whom receive healthcare coverage from Medicaid, will be affected
In response to the change, MD Anderson and the American Lung Association have released an online toolkit loaded with new series of materials to help state and local officials and public health advocates increase coverage and access to evidence-based tobacco cessation treatments for Medicaid enrollees who want to quit smoking.
“This online toolkit will make it easier for public housing administrators, as well as healthcare providers, get the information they need to assist residents in their quit attempt in an effort to eliminate tobacco use and tobacco-related cancers,” said Jennifer Cofer, director of MD Anderson’s EndTobacco® Program, an initiative of the Moon Shots Program™’s cancer prevention and control platform.
According to a recent report from the Centers for Disease Control and Prevention, only 10 states have Medicaid programs that cover all seven FDA-approved tobacco-cessation medications, as well as individual and group counseling. Forty-eight states have barriers to treatment options that make it more difficult for Medicaid-enrolled smokers to access treatment and potentially quit.
The toolkit materials include factsheets, template materials, webinar information, healthcare provider resources, quit-smoking resources and important links to external information. The materials are available at www.lung.org/cessation-toolkit.
